FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections

mBio

Volumn 3, Issue 2, 2012, Pages

  Nesta, Barbara ^a   Spraggon, Glen ^b   Alteri, Christopher ^c   Moriel, Danilo Gomes ^a   Rosini, Roberto ^a   Veggi, Daniele ^a   Smith, Sara ^c   Bertoldi, Isabella ^a   Pastorello, Ilaria ^a   Ferlenghi, Ilaria ^a   Fontana, Maria Rita ^a   Frankel, Gad ^d   Mobley, Harry L T ^c   Rappuoli, Rino ^a   Pizza, Mariagrazia ^a   Serino, Laura ^a   Soriani, Marco ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL VACCINE; CHOLERA TOXIN; ESCHERICHIA COLI PROTEIN; FACTOR ADHERENCE ESCHERICHIA COLI VACCINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; CELL ADHESION; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; FDEC GENE; FEMALE; GENE EXPRESSION; IMAGE ANALYSIS; IMAGE PROCESSING; IMMUNIZATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; TISSUE DISTRIBUTION; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA; MUS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 84860539742     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00010-12     Document Type: Article

References (36)

1. Bielaszewska M, et al. 2011. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect. Dis. 11:671-676.
2. Russo TA, Johnson JR. 2000. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181:1753-1754.
3. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 5:449-456.
4. Gransden WR, Eykyn SJ, Phillips I, Rowe B. 1990. Bacteremia due to Escherichia coli: a study of 861 episodes. Rev. Infect. Dis. 12:1008-1018.
5. Zhang L, Foxman B. 2003. Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front. Biosci. 8:e235-e244.
6. Mysorekar IU, Hultgren SJ. 2006. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl. Acad. Sci. U. S. A. 103:14170-14175.
7. Winberg J, Bergström T, Jacobsson B. 1975. Morbidity, age and sex distribution, recurrences and renal scarring in symptomatic urinary tract infection in childhood. Kidney Int. Suppl. 4:S101-S106.
8. Ruben FL, et al. 1995. Clinical infections in the noninstitutionalized geriatric age group: methods utilized and incidence of infections. The Pittsburgh Good Health Study. Am. J. Epidemiol. 141:145-157.
9. Kucheria R, Dasgupta P, Sacks SH, Khan MS, Sheerin NS. 2005. Urinary tract infections: new insights into a common problem. Postgrad. Med. J. 81:83-86.
10. Moriel DG, et al. 2010. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 107:9072-9077.
11. Isberg RR, Voorhis DL, Falkow S. 1987. Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 50:769-778.
12. Luo Y, et al. 2000. Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex. Nature 405:1073-1077.
13. Chen Q, Savarino SJ, Venkatesan MM. 2006. Subtractive hybridization and optical mapping of the enterotoxigenic Escherichia coli H10407 chromosome: isolation of unique sequences and demonstration of significant similarity to the chromosome of E. coli K-12. Microbiology 152: 1041-1054.
14. Hamburger ZA, Brown MS, Isberg RR, Bjorkman PJ. 1999. Crystal structure of invasin: a bacterial integrin-binding protein. Science 286: 291-295.
15. Lehti TA, et al. 2010. Mat fimbriae promote biofilm formation by meningitis-associated Escherichia coli. Microbiology 156:2408-2417.
16. Ulett GC, Mabbett AN, Fung KC, Webb RI, Schembri MA. 2007. The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation. Microbiology 153:2321-2331.
17. Trautner BW, Darouiche RO. 2004. Role of biofilm in catheterassociated urinary tract infection. Am. J. Infect. Control 32:177-183.
18. Ha US, Cho YH. 2006. Catheter-associated urinary tract infections: new aspects of novel urinary catheters. Int. J. Antimicrob. Agents 28:485-490.
19. Bomchil N, Watnick P, Kolter R. 2003. Identification and characterization of a Vibrio cholerae gene, mbaA, involved in maintenance of biofilm architecture. J. Bacteriol. 185:1384-1390.
20. Rasko DA, et al. 2008. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J. Bacteriol. 190:6881-6893.
21. Oshima K, et al. 2008. Complete genome sequence and comparative analysis of the wild-type commensal Escherichia coli strain SE11 isolated from a healthy adult. DNA Res. 15:375-386.
22. Snyder JA, et al. 2005. Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect. Immun. 73:7588-7596.
23. Achtman M, et al. 1983. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect. Immun. 39:315-335.
24. Hacker J, et al. 1985. Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect. Immun. 47:434-440.
25. Mobley HL, et al. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
26. Blattner FR, et al. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1462.
27. Hayashi K, et al. 2006. Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol. Syst. Biol. 2:2006.0007.
28. Page R, et al. 2003. Shotgun crystallization strategy for structural genomics: an optimized two-tiered crystallization screen against the Thermotoga maritima proteome. Acta Crystallogr. D Biol. Crystallogr. 59: 1028-1037.
29. Stevens RC, et al. 2002. An approach to rapid protein crystallization using nanodroplets. J. Appl. Crystallogr. 35:278-281.
30. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50:760-763.
31. McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ. 2005. Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 61:458-464.
32. Murshudov GN, Vagin AA, Dodson EJ. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53:240-255.
33. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132.
34. Krissinel E, Henrick K. 2004. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60:2256-2268.
35. Hagberg L, et al. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283.
36. Kuenne CT, Ghai R, Chakraborty T, Hain T. 2007. GECO-linear visualization for comparative genomics. Bioinformatics 23:125-126.